Ann: Successful OrthoATI clinical trial, page-47

Hopefully hold above 40c but who knows?. It's frustrating that results these days in the space are not rewarded like they use too but that might be the new norm -too many burnt in the past? Good value given it's depressed price and 2-3 years down the track. Hopefully they give a clear path to TGA approval first up. The US is great but they will need a largish trial I guess 200+ and it will be time consuming and cost a bit. I'm ok with the progress though and that what counts to me. It may be 3-5 years before significant rewards but hopefully striate catches on fast and there's another revenue stream not too far behind. GLTA